UK Supplement Frequent Urination Relief Ad Claim Gets Medical Experts' Assist
This article was originally published in The Rose Sheet
Executive Summary
The UK's independent advertising watchdog says Omega Pharma Ltd. did not imply its Urostemol Men herbal product was suitable to treat any medical condition other than the one indicated in onscreen text, "for the relief of lower urinary tract symptoms related to an overactive bladder, based on long-standing use."
You may also be interested in...
Industry Roundup: GMP Warnings, Spiked Product Recall, UK Ads
Food or supplement at Summit Beverage? Merck & Co. venture arm adds European director; meetings on import safety programs; and more news in brief.
US Health And Wellness People News: CHPA, Bayer, Viatris, Qnovia, Powerade
Sanofi consumer health scientific affairs lead moves to CHPA; change in Bayer’s US consumer health marketing helm; Viatris CCO moves from same post at Moderna; Qnovia expands scientific advisory board; and Powerade powers Girls Inc. scholarships, programs.
Australian Teeth Whitener Marketer Frowns On Industry Self-Regulation Referencing US Laws
HiSmile appeals NAD recommendation following review on P&G challenge to discontinue ad claims on its website and in social media videos stating peroxide-containing whitening products are “painful” or cause pain, break down and impact gums and teeth, or “damage” gums.